Abiopharma

News list

📋 HAROLD SELICK (Director) plans to sell 24K shares of PROTAGONIST THERAPEUTICS, INC. (at $105.00 each, total $2.5M) Filed: Mar 26, 2026 | ID: 003020

Full text

News bot March 26, 2026, 8:06 p.m.
📋 Form 144 Filing: HAROLD SELICK

Company: PROTAGONIST THERAPEUTICS, INC.

Filing Date: 2026-03-26

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 24,000
- Price per Share: $105.00
- Total Value: $2,520,000.00
- Planned Sale Date: 2026-03-26
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-37852
- Issuer Contact Phone: (510) 474-0170
- Issuer Address: 7707 Gateway Boulevard, Suite 140, Newark, CA, 94560-1160
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 63808716.0
- Number of Securities to be Sold: 1
- Signature: /s/ Harold E. Selick